Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Moodys
Teva
Johnson and Johnson
UBS
Julphar
Harvard Business School
AstraZeneca
Citi
McKesson

Generated: October 22, 2017

DrugPatentWatch Database Preview

KEFTAB Drug Profile

« Back to Dashboard

Which patents cover Keftab, and when can generic versions of Keftab launch?

Keftab is a drug marketed by Lilly and is included in one NDA.

The generic ingredient in KEFTAB is cephalexin hydrochloride. There are twenty-nine drug master file entries for this compound. Additional details are available on the cephalexin hydrochloride profile page.

Summary for Tradename: KEFTAB

US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list33
Clinical Trials: see list1
Patent Applications: see list147
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:KEFTAB at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly
KEFTAB
cephalexin hydrochloride
TABLET;ORAL050614-001Oct 29, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Lilly
KEFTAB
cephalexin hydrochloride
TABLET;ORAL050614-003May 16, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Lilly
KEFTAB
cephalexin hydrochloride
TABLET;ORAL050614-002Oct 29, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Chinese Patent Office
Fuji
Cantor Fitzgerald
Merck
McKesson
Healthtrust
Argus Health
Colorcon
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot